Slate Path Capital LP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 86 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Slate Path Capital LP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2020$6,119,000
+71.2%
420,0000.0%0.36%
+31.8%
Q1 2020$3,574,000
-47.0%
420,000
-11.6%
0.27%
+33.7%
Q4 2016$6,745,000
-33.6%
475,0000.0%0.20%
+21.3%
Q3 2016$10,160,000
+7.5%
475,000
+13.1%
0.17%
-77.1%
Q2 2016$9,454,000420,0000.74%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$3,280,00010.95%
M28 Capital Management LP 439,300$1,440,9041.37%
Redmile Group, LLC 6,242,756$20,476,2400.84%
MAVERICK CAPITAL LTD 6,291,013$20,634,5230.49%
Baupost Group 8,123,616$26,6450.44%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 52,000$1710.25%
WASATCH ADVISORS LP 8,391,014$27,522,5250.18%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$1,722,0000.17%
STALEY CAPITAL ADVISERS INC 450,000$1,4760.09%
Virtus ETF Advisers LLC 36,100$118,4080.06%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders